Yucca Health vs Maximus: Price, meds, and access compared
Quick verdict: Yucca Health (TryYucca) is best if you want both compounded semaglutide and tirzepatide plus BNPL options, while Maximus is best if your primary goal is the lowest flat monthly price for compounded semaglutide. This comparison looks at pricing, medication options, approval and shipping, financing and payment, and scale and track record to make the differences clear for Yucca Health vs Maximus.
See Yucca Health plans and pricing
Head-to-head summary
Both platforms provide telemedicine prescribing and use U.S. pharmacies to fill compounded semaglutide. Key distinctions are price points, availability of tirzepatide, financing options, approval speed, and public track record.
Distinctive differences explained
1. Price and plan structure
Maximus advertises a low flat rate of $132.99 per month for compounded semaglutide. Yucca Health lists compounded semaglutide starting at $146 per month and compounded tirzepatide starting at $258 per month. Yucca Health also offers a 6 month semaglutide plan at $875 that locks in the best per month rate according to its materials. All pricing is direct-pay; neither provider accepts health insurance according to the source.
View Maximus pricing and sign up
2. Medication variety: semaglutide and tirzepatide
Yucca Health explicitly offers both compounded semaglutide and compounded tirzepatide, with tirzepatide noted as a dual GIP/GLP-1 option. Maximus documentation focuses on compounded semaglutide and provides limited published detail on tirzepatide availability. If tirzepatide matters to you, Yucca Health provides that option in its program.
3. Approval speed, shipping, and payment options
Yucca Health promotes fast online approval within 24 hours and UPS 2-Day Air shipping on most orders, plus Buy Now Pay Later via Klarna, Afterpay, and Affirm. Maximus highlights convenient telemedicine access and free priority or expedited shipping in its materials. Maximus emphasizes a no in-person visit workflow and prescriptions approved by licensed doctors.
4. Scale and public track record
Yucca Health cites 20,000+ active patients and a 4.6 TrustPilot rating in its marketing. Maximus is described as a smaller, newer platform with fewer public reviews and a thinner public track record. Both platforms use licensed providers and U.S. pharmacies for compounding. The sources note that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality.
Comparison table
| Criteria | Yucca Health | Maximus |
|---|---|---|
| Starting price for semaglutide | $146/month (compounded) | $132.99/month (compounded) |
| Tirzepatide availability | Offered, starting at $258/month | Limited published detail on availability |
| Approval and shipping | Online review typically 24 hours; UPS 2-Day Air | Telemedicine approval; free priority or expedited shipping |
| Financing and payment | Klarna, Afterpay, Affirm available; no insurance | Direct-pay model; no insurance noted |
| Public track record | 20,000+ active patients; 4.6 TrustPilot rating reported | Smaller platform with fewer public reviews reported |
How the programs work and clinical notes
Both programs use licensed clinicians to review patient submissions and issue prescriptions when medically appropriate. Yucca Health describes a physician-led clinical review and compounding at licensed U.S. pharmacies. Maximus states prescriptions are approved by licensed doctors and filled through trusted U.S. pharmacies. Both sources include the regulatory note that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality.
Pros and cons side by side
Yucca Health pros in source materials include availability of both semaglutide and tirzepatide, multiple BNPL options, fast 24-hour approval, and a larger cited patient base. Cons include no branded FDA-approved medications and no insurance acceptance. Maximus pros include a lower flat monthly rate for semaglutide, telemedicine convenience, and prescriptions approved by licensed doctors. Maximus cons include a smaller public track record and limited published details about tirzepatide.
Explore Yucca Health tirzepatide option
Conclusion: Yucca Health vs Maximus
For Yucca Health vs Maximus the decision boils down to medication choice and price. Maximus is the lower flat-rate option for compounded semaglutide at $132.99/month. Yucca Health costs more for semaglutide on a monthly basis but adds compounded tirzepatide and multiple BNPL options, plus reported faster approval and a larger patient base. Both use licensed clinicians and U.S. pharmacies and both clarify that compounded medications are not FDA-approved finished products.
Choose Yucca Health if you want both semaglutide and tirzepatide access, BNPL payment options, and a platform with a larger reported patient base. Choose Maximus if your priority is the lowest advertised monthly price for compounded semaglutide and a simple telemedicine workflow.